Year: 2015

New Board member

  • 15:19

The Nomination Committee of Immunicum AB (publ) proposes that Magnus Persson be elected as a new member of… Read more

Director Clinical Operations

  • 15:23

Immunicum AB (publ) strengthens its organization with the recruitment of Linda Barkemo as Director Clinical Operations. Linda Barkemo… Read more

Improved RCC I/II-data

  • 09:13

Immunicum AB (publ) today announced continued improvement in survival data from the follow-up phase of a clinical phase… Read more

New CFO

  • 20:27

Immunicum AB (publ) strengthens its organization with the recruitment of Lise-Lotte Hallbäck as CFO. Read the press release… Read more

Company presentation

  • 15:18

CEO, Jamal El-Mosleh, holds a company presentation at “Småbolagsdagen”. See the presentation (in Swedish) here: Presentation

Interim report

  • 08:58

Immunicum published interim report for the period 140701-150331. Read the report (in Swedish) here: Immunicum 140701-150331

Company presentation

  • 14:31

CEO, Jamal El-Mosleh, holds a company presentation at Redeye. See the presentation (in Swedish) here: Company presentation Redeye… Read more

FPI phase II RCC

  • 09:07

Immunicum AB (publ) today announced that the first patient has been included in the international phase II study… Read more

HCC clarification

  • 16:12

Immunicum AB (publ) today announced a clarification in response to several questions on Immunicum’s update on the HCC… Read more

HCC update

  • 13:31

Immunicum AB (publ) today reported updated safety and survival data in the ongoing phase I/II study with INTUVAX… Read more